Rituximab in Children with Steroid-Dependent Nephrotic Syndrome: A Multicenter, Open-Label, Noninferiority, Randomized Controlled Trial.
about
Pathogenesis of minimal change nephrotic syndrome: an immunological conceptNephrotic syndrome: what's new, what's hot?The oculocerebrorenal syndrome of Lowe: an updateRituximab for nephrotic syndrome in children.The Evidence-Based Approach to Adult-Onset Idiopathic Nephrotic Syndrome.Anti-CD20 Antibodies for Idiopathic Nephrotic Syndrome in Children.Randomised controlled trial comparing ofatumumab to rituximab in children with steroid-dependent and calcineurin inhibitor-dependent idiopathic nephrotic syndrome: study protocol.Regulatory T cells and minimal change nephropathy: in the midst of a complex network.Steroid-sensitive nephrotic syndrome: an evidence-based update of immunosuppressive treatment in children.Cyclophosphamide and rituximab in frequently relapsing/steroid-dependent nephrotic syndrome.High-Dose Rituximab Ineffective for Focal Segmental Glomerulosclerosis: A Long-Term Observation Study.Rituximab in Minimal Change Disease: Mechanisms of Action and Hypotheses for Future Studies.Highlights of the 2015 ERA-EDTA Congress--glomerular diseases.Immunology of idiopathic nephrotic syndrome.Rituximab and protection from vaccine preventable diseases: applying the evidence to pediatric patients.Rituximab in children with steroid-dependent nephrotic syndrome: experience of a tertiary center and review of the literature.How randomised trials have improved the care of children with kidney disease.Idiopathic nephrotic syndrome: the EBV hypothesis.Proteinuria in Dent disease: a review of the literature.Short courses of daily prednisolone during upper respiratory tract infections reduce relapse frequency in childhood nephrotic syndrome.Recent Treatment Advances and New Trials in Adult Nephrotic Syndrome.Rituximab in steroid-sensitive nephrotic syndrome: lessons from clinical trials.Predictors of relapse and long-term outcome in children with steroid-dependent nephrotic syndrome after rituximab treatment.Mycophenolic Acid Pharmacokinetics and Relapse in Children with Steroid-Dependent Idiopathic Nephrotic Syndrome.Nephrotic syndrome in infants and children: pathophysiology and management.B Cell Reconstitution after Rituximab Treatment in Idiopathic Nephrotic Syndrome.Toll-like receptor 3 expression and function in childhood idiopathic nephrotic syndrome.Long-term repeated rituximab treatment for childhood steroid-dependent nephrotic syndrome.Low-dose ofatumumab for rituximab-resistant nephrotic syndrome.The efficacy and safety of rituximab in treating childhood nephrotic syndrome: an Italian perspective.Difficult-to-treat idiopathic nephrotic syndrome: established drugs, open questions and future options.Busy BsA mild form of rituximab-associated lung injury in two adolescents treated for nephrotic syndrome.Ofatumumab for the treatment of childhood nephrotic syndrome.Adverse events linked with the use of chimeric and humanized anti-CD20 antibodies in children with idiopathic nephrotic syndrome.Montelukast as an add-on treatment in steroid dependant nephrotic syndrome, randomised-controlled trial.Ofatumumab in two pediatric nephrotic syndrome patients allergic to rituximab.Clinical trials in minimal change disease.Molecular and Cellular Mechanisms for Proteinuria in Minimal Change Disease.
P2860
Q26747387-DD52AA5B-BF69-4BE7-B4F8-1EA607A62E7CQ26782879-B946EAB3-DC52-4CCF-8102-7624426AC7BFQ28075516-22B8FA86-2FB0-4A17-AE7E-BBB6D7047053Q33555088-C5A91519-4BC7-43E4-9F57-3F53CE911F55Q36098017-68EFDCDB-4C67-492B-B07B-E7D782E8079DQ36770915-D5736DD8-F763-44D6-92E2-2FB42E548B12Q37728395-C6F55A8C-E859-4B0E-94E8-CCC1781FCEB6Q38543132-76FB6F28-CEE1-4C2F-B6EF-013A0CBB35F3Q38569641-FBCB6536-BD06-40B7-B5E4-47C80387005DQ38622603-7AFC1DB0-A343-431B-8C5A-99C7D7687289Q38658597-4DCA3010-14D2-40B2-BF64-1DB4AF508A47Q38679589-7B170FDE-3432-4275-87BB-7BA3193FE93BQ38695675-2C64F38C-64DC-45A6-BFC6-30C61C8D5AF7Q38815449-88A24205-9629-4683-9042-ED0DE367C4B4Q38842494-F3134187-FAAF-4244-9FAA-09297203A44EQ38895019-A8649AD7-6CA4-4422-8F59-3BFAD3BF6187Q38917590-86C3161A-87F7-425D-B4C8-39F18599967CQ38967341-44906474-1CA2-46A1-AC1C-52A81929902BQ38984932-60A1133A-8838-4AE0-8EAC-56CEBEECE8F5Q39200037-8071ECD1-D9DA-42DD-9024-287AC00A6A6FQ39335899-2E824005-491B-4F31-9B5D-147A5EF17817Q39440837-84A48061-27CE-4026-B7DC-583872E75FDFQ39456170-278DAFDA-AF5C-40FB-A2B3-EF8DC11DEE9FQ39573394-FE7D30A3-3105-4240-933C-098752F20A85Q40039238-E3CC6276-D4B7-40DC-8CB9-35768B1ADC68Q41124267-62E1BB2E-09EE-41C6-B78B-68E355B97E86Q41132115-262D9956-F685-4F56-989A-3A733D678A29Q41387077-09CE1454-FB19-480F-8448-72FCAE5DB4A7Q41728530-15D118D7-E6C2-4505-9906-6E8302600E9AQ42424215-0B5CEB1D-728C-49BC-AC56-373CED08F1D3Q42688626-7133025C-D42E-4AB8-98AF-9B6F52B0CCA4Q42754554-749C2D20-B772-48D7-BF68-F8EC6FA1A0BEQ46191931-CE8F98C8-24AE-4734-B148-673C9AD2F9BFQ48221532-5BB96668-2FE5-4A83-93BB-10C202FC9147Q50047399-E2A476E2-82C9-44DB-9315-0A617D21D5D1Q51536098-73E59BC6-F09F-44EB-8CE0-613750292EFDQ52846398-3F2DE588-3807-4C2D-A89A-C0BEBB5291C2Q53368686-E10DE199-FEA8-4937-8C03-EAB2E22FCE97Q55251661-6C2A6A19-8234-4F58-A34F-C62450EA5021
P2860
Rituximab in Children with Steroid-Dependent Nephrotic Syndrome: A Multicenter, Open-Label, Noninferiority, Randomized Controlled Trial.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Rituximab in Children with Ste ...... , Randomized Controlled Trial.
@ast
Rituximab in Children with Ste ...... , Randomized Controlled Trial.
@en
type
label
Rituximab in Children with Ste ...... , Randomized Controlled Trial.
@ast
Rituximab in Children with Ste ...... , Randomized Controlled Trial.
@en
prefLabel
Rituximab in Children with Ste ...... , Randomized Controlled Trial.
@ast
Rituximab in Children with Ste ...... , Randomized Controlled Trial.
@en
P2093
P2860
P50
P356
P1476
Rituximab in Children with Ste ...... , Randomized Controlled Trial.
@en
P2093
Alessia Fornoni
Donatella De Giovanni
Felice Sica
Francesco Scolari
Giancarlo Barbano
Jochen Reiser
Ludovica Degl'Innocenti
Mirco Belingheri
Monica Bodria
Pietro Ravani
P2860
P304
P356
10.1681/ASN.2014080799
P577
2015-01-15T00:00:00Z